Header cover image

Indian (NIFTY) Healthcare Sector Analysis

UpdatedNov 28, 2021
DataAggregated Company Financials
Companies218
  • 7D1.6%
  • 3M-1.5%
  • 1Y24.7%
  • YTD15.5%

Over the last 7 days, the Healthcare industry has risen 1.6%, driven by gains from Cipla of 8.3%. This takes the industry's 12 month performance to a gain of 25%.

Sector Valuation and Performance

Has the Indian Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Sun, 28 Nov 2021₹14.9t₹3.4t₹435.3b25x
Tue, 26 Oct 2021₹14.6t₹3.3t₹442.8b25.3x
Thu, 23 Sep 2021₹15.5t₹3.3t₹440.6b27.1x
Sat, 21 Aug 2021₹14.9t₹3.3t₹439.1b25.7x
Sat, 05 Jun 2021₹14.0t₹3.1t₹364.6b24.1x
Tue, 09 Mar 2021₹11.9t₹3.0t₹349.5b21.6x
Mon, 30 Nov 2020₹11.7t₹3.0t₹269.2b24.7x
Thu, 03 Sep 2020₹10.3t₹2.9t₹236.8b23.8x
Sun, 07 Jun 2020₹8.7t₹2.9t₹262.6b18.4x
Sat, 29 Feb 2020₹7.6t₹2.9t₹245.9b16.8x
Tue, 03 Dec 2019₹7.5t₹2.8t₹269.4b18x
Fri, 06 Sep 2019₹6.9t₹2.7t₹257.0b17.6x
Mon, 10 Jun 2019₹7.1t₹2.6t₹241.1b20.4x
Sun, 03 Mar 2019₹7.3t₹2.5t₹213.1b21.7x
Wed, 05 Dec 2018₹7.7t₹2.4t₹202.6b22.6x
PE Ratio

22.6x

Total Market Cap: ₹7.7tTotal Earnings: ₹202.6bTotal Revenue: ₹2.4t0%0%0%3 Year10 Year
201920202021

Current Industry PE: Investors are relatively neutral on the industry at the moment, considering it's trading close to its 3-year average PE ratio of 21.0x. It appears they believe that earnings will grow in-line with historical growth rates.

Past Earnings Growth: The earnings for companies in the Healthcare industry have grown 29% per year over the last three years, and revenues for these companies have grown 11% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Indian Healthcare sector?

Medical Equipment7.09%
Life Sciences2.08%
Pharma1.70%
Healthcare Services0.89%
Healthtech-0.32%
Biotech-0.95%

Industry PE: Investors are most optimistic about the Biotech industry which is trading above its 3-year average PE ratio of 45.0x. This is likely because analysts are expecting annual earnings growth of 43%, which is higher than its past year's earnings growth of 31% per year. Meanwhile, investors are most pessimistic about the Pharma industry. Although, investor sentiment seems to have improved given its trading above its 3-year average of 19.3x.

Forecasted Growth: Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 43% over the next 5 years. This is better than it's past earnings growth rate of 31% per year. Meanwhile, the Healthcare Services industry is expected to see its earnings grow by 17% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

Company7D1YValuation
CIPLA Cipla8.3%+₹60.1b29.7%PE30.1x
500420 Torrent Pharmaceuticals9.0%+₹42.4b16.3%PE40.6x
DIVISLAB Divi's Laboratories3.2%+₹40.4b37.0%PE61.4x
AUROPHARMA Aurobindo Pharma6.1%+₹22.9b-21.9%PE7.6x
540222 Laurus Labs8.6%+₹22.3b65.0%PE27.7x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News